Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease
Clinical trial NCT01284387 · COMPLETED
Trial details
- NCT number
- NCT01284387
- Sponsor
- JANSSEN Alzheimer Immunotherapy Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2014-01-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.